These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9327891)

  • 21. Transport mechanisms in acetylcholine and monoamine storage.
    Parsons SM
    FASEB J; 2000 Dec; 14(15):2423-34. PubMed ID: 11099460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurogenetics of synaptic transmission in Caenorhabditis elegans.
    Rand JB; Duerr JS; Frisby DL
    Adv Pharmacol; 1998; 42():940-4. PubMed ID: 9328053
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
    Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.
    Waites CL; Mehta A; Tan PK; Thomas G; Edwards RH; Krantz DE
    J Cell Biol; 2001 Mar; 152(6):1159-68. PubMed ID: 11257117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Caenorhabditis elegans to study vesicular transport.
    Rand JB; Duerr JS; Frisby DL
    Methods Enzymol; 1998; 296():529-47. PubMed ID: 9779472
    [No Abstract]   [Full Text] [Related]  

  • 28. Ontogeny of vesicular amine transporter expression in the rat: new perspectives on aminergic neuronal and neuroendocrine differentiation.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Adv Pharmacol; 1998; 42():903-8. PubMed ID: 9328044
    [No Abstract]   [Full Text] [Related]  

  • 29. Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
    Frey KA; Wieland DM; Kilbourn MR
    Adv Pharmacol; 1998; 42():269-72. PubMed ID: 9327896
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).
    Roghani A; Carroll PT
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):21-30. PubMed ID: 12008018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration.
    Lu W; Wolf ME
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):137-48. PubMed ID: 9387873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.
    Pothos EN; Larsen KE; Krantz DE; Liu Y; Haycock JW; Setlik W; Gershon MD; Edwards RH; Sulzer D
    J Neurosci; 2000 Oct; 20(19):7297-306. PubMed ID: 11007887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes.
    Anlauf M; Schäfer MK; Eiden L; Weihe E
    J Comp Neurol; 2003 Apr; 459(1):90-111. PubMed ID: 12629668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system.
    Burger S; Döring B; Hardt M; Beuerlein K; Gerstberger R; Geyer J
    Neuroscience; 2011 Oct; 193():109-21. PubMed ID: 21742018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of vesicular amine transporter function and targeting to secretory organelles.
    Erickson JD; Varoqui H
    FASEB J; 2000 Dec; 14(15):2450-8. PubMed ID: 11099462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular neurotransmitter transport and the presynaptic regulation of quantal size.
    Reimer RJ; Fon EA; Edwards RH
    Curr Opin Neurobiol; 1998 Jun; 8(3):405-12. PubMed ID: 9687352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of the rat vesicular acetylcholine transporter.
    Kim MH; Lu M; Rogers G; Parsons S; Hersh LB
    Neurochem Res; 2003 Apr; 28(3-4):473-6. PubMed ID: 12675133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine.
    Eiden LE; Schäfer MK; Weihe E; Schütz B
    Pflugers Arch; 2004 Feb; 447(5):636-40. PubMed ID: 12827358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VIP and NPY expression during differentiation of cholinergic and noradrenergic sympathetic neurons.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Ann N Y Acad Sci; 1998 Dec; 865():537-41. PubMed ID: 9928065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.